Suven Life Sciences Limited Sustainability Profile
Suven Life Sciences Limited, a prominent player in the pharmaceutical and biotechnology sectors, is headquartered in Hyderabad, India. Founded in 1989, the company has established itself as a leader in drug discovery and development, focusing on central nervous system disorders and other therapeutic areas. With a robust portfolio of innovative products and services, Suven Life Sciences is renowned for its unique approach to developing novel compounds that address unmet medical needs. The company has achieved significant milestones, including successful collaborations and partnerships that enhance its market position. Operating primarily in India and expanding its reach globally, Suven Life Sciences continues to make strides in the industry, driven by a commitment to research excellence and patient-centric solutions.
DitchCarbon Score
How does Suven Life Sciences Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Suven Life Sciences Limited's score of 24 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Suven Life Sciences Limited's reported carbon emissions
In 2024, Suven Life Sciences Limited reported total emissions of approximately 915,600 kg CO2e, comprising 32,090 kg CO2e from Scope 1 and 883,510 kg CO2e from Scope 2 emissions. The previous year, 2023, the company recorded total emissions of about 888,620 kg CO2e, with Scope 1 emissions at 30,540 kg CO2e and Scope 2 emissions at 858,080 kg CO2e. Suven Life Sciences Limited has not disclosed any Scope 3 emissions data, and there are currently no specific reduction targets or climate pledges outlined in their reports. The emissions data is cascaded from the parent company, reflecting the company's commitment to transparency in its environmental impact. Overall, while Suven Life Sciences Limited has made strides in reporting its emissions, further commitments and reduction initiatives would enhance its climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 31,101 | 00,000 | 00,000 |
| Scope 2 | 859,118 | 000,000 | 000,000 |
| Scope 3 | - | - | - |
How Carbon Intensive is Suven Life Sciences Limited's Industry?
How Carbon Intensive is Suven Life Sciences Limited's Location?
Suven Life Sciences Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Suven Life Sciences Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Anthem Biosciences
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.